Table 1.
Patients’ characteristics.
| Patients’ Characteristics | n (%) |
|---|---|
| Patients | 20 |
| Female | 12 (60%) |
| Age | |
| <25 years | 4 (20%) |
| 25–44 years | 16 (80%) |
| Marital status: | |
| Married | 5 (25%) |
| Unmarried | 15 (75%) |
| Residence | |
| Urban area | 9 (45%) |
| Rural area | 11 (55%) |
| Educational level | |
| <Bachelor’s degree | 1 (5%) |
| Bachelor’s degree | 5 (25%) |
| >Bachelor’s degree | 14 (70%) |
| Disease | |
| Ulcerative colitis | 7 (35%) |
| Crohn’s disease | 13 (65%) |
| Disease duration | |
| <1 year | 2 (10%) |
| 1–5 years | 7 (35%) |
| 6–10 years | 5 (25%) |
| >11 years | 6 (30%) |
| CD location | |
| Ileitis | 3 (23%) |
| Colitis | 1 (8%) |
| Ileocolitis | 9 (69%) |
| UC location | |
| Extensive colitis | 5 (71%) |
| Left-side colitis | 2 (29%) |
| Proctitis | 0 |
| Smoking status | |
| Active smoker | 5 (25%) |
| Former smoker | 1 (5%) |
| Non-smoker | 14 (70%) |
| Perianal disease | 3 (15%) |
| Upper disease | 1 (5%) |
| Surgery | 6 (30%) |
| Clinical disease activity | |
| Harvey-Bradshaw Index, mean ± standard deviation | 2.15 ± 1.72 |
| Partial Mayo score, mean ± standard deviation | 2.42 ± 2.63 |
| Medications | |
| Local steroid | 6 (30%) |
| Systemic steroid | 12 (60%) |
| 5-ASA | 8 (40%) |
| Thiopurine | 9 (45%) |
| Methotrexate | 4 (20%) |
| Infliximab | 9 (45%) |
| Adalimumab | 11 (55%) |
| Vedolizumab | 4 (20%) |
| Ustekinumab | 4 (20%) |
| Current quality of life | |
| 7 Completely satisfactory | 4 (20%) |
| 6 Satisfactory | 3 (15%) |
| 5 Quite satisfactory | 3 (15%) |
| 4 Indifferent | 3 (15%) |
| 3 Quite unsatisfactory | 4 (20%) |
| 2 Not satisfactory | 3 (15%) |
| 1 Not at all satisfactory | 0 |
| Membership in an association for IBD patients | |
| Yes | 5 (25%) |
| No | 15 (75%) |
| Frequency of smartphone use | |
| 7 Completely regular | 11 (55%) |
| 6 Regular | 3 (15%) |
| 5 Quite regular | 6 (30%) |
| 4 Indifferent | 0 |
| 3 Quite not regular | 0 |
| 2 Not regular | 0 |
| 1 Not at all regular | 0 |
5-ASA: mesalazine.